AbbVie Inc. Employee Benefits and Share-based Compensation
AbbVie Inc. (ABBV) reported Employee Benefits and Share-based Compensation of $95.00 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-04.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2025-11-04
- AbbVie Inc. employee benefits and share-based compensation for the quarter ending 2025-09-30 was $95.00M, a 40.99% decline year-over-year.
- AbbVie Inc. employee benefits and share-based compensation for the quarter ending 2024-09-30 was $161.00M.
- AbbVie Inc. employee benefits and share-based compensation for the quarter ending 2024-06-30 was $0.00.
- AbbVie Inc. employee benefits and share-based compensation for the quarter ending 2024-03-31 was $349.00M.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month |
|---|---|---|---|
| 2025-09-30 | $95.00M 10-Q · filed 2025-11-04 | $95.00M 10-Q · filed 2025-11-04 | |
| 2024-09-30 | $161.00M 10-Q · filed 2025-11-04 | $161.00M derived: sum of 2 quarters · filed 2025-11-04 | $510.00M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $349.00M 10-Q · filed 2025-08-04 | |
| 2024-03-31 | $349.00M 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |